Regularization of appointment of Mr Swanith Kapoor as Director and reappointment of Mr Aditya Arora as WTD of the company

Date: September 02, 2026 The Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers 25th Floor, Dalal Street, Mumbai- 400001 Company Scrip Code: 539997 Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015) Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and further to our intimation dated 09th August, 2026 we wish to inform you that the members of Kwality Pharmaceuticals Limited (“the Company”) at the 43rd Annual General Meeting of the Company held on August 31, 2026 inter alia, have considered and approved: 1. Regularization of appointment of Mr. Swanith Kapoor (DIN: 11662482), as the Non- Executive Independent Director of the Company for a term of 5 (Five) consecutive years with effect from 02nd June, 2026 to 01st June, 2031. The details as required are provided in Annexure-A to this letter. 2. Reappointment of Mr. Aditya Arora (DIN: 07320410), as Whole Time Director of the Company for a period of 5 years with effect from 30th September 2026 to 29th September 2031. The details as required are provided in Annexure-B to this letter. The above information is also available on the website of the Company www.kwalitypharma.com. You are requested to kindly take the same on record. Thanking You, Yours truly, For Kwality Pharmaceuticals Limited Gurpreet Kaur Company secretary & Compliance Officer Annexure A Details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 S.NO Details of events that need to be Information of such events Provided 1 Reason for change viz. Regularization of appointment of Mr. Swanith Kapoor (DIN: appointment/re-appointment, 11662482) as Non-Executive Independent Director of the Company. resignation, removal, death or otherwise. 2 Date of Appointment/Re- With effect from 02nd June, 2026 appointment, Cessation (as applicable) 3 Term of appointment/ re- The members at its meeting held on August 31, 2026, has appointment approved the appointment of Mr. Swanith Kapoor (DIN: 11662482), as Non-Executive Independent Director of the Company for a period of 5 (five) consecutive years w.e.f. 02nd June, 2026 to 01st June, 2031. 4 brief profile (in case of Mr. Swanith Kapoor is a qualified legal professional. He holds a Appointment/Re-appointment B.B.A. LL.B. (Hons.) with specialization in Corporate Law from the School of Law, University of Petroleum and Energy Studies, Dehradun, Uttrakhand and was awarded the University Silver Medal. He has also completed a Post Graduate Diploma in Medical Law and Ethics from NLSIU, Bengaluru, and is currently pursuing a Master's in Business Laws from NLSIU, Bengaluru. He has worked as a Legal Intern with TCS, Mumbai and Dhir & Dhir Law Offices, New Delhi. 5 Disclosure of relationships between Mr. Swanith Kapoor is not related to any Director of the Company. Directors 6 Information as required pursuant to Mr. Swanith Kapoor is not debarred from holding the office of BSE Circular with ref. no. Director by virtue of any SEBI order or any such authority. LIST/COMP/14/2018-19 Annexure B Details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 S.NO Details of events that need to be Information of such events Provided 1. Reason for change viz. appointment/re- Re-appointment of Mr. Aditya Arora (DIN: 07320410) as Whole appointment, resignation, removal, Time Director of the Company. death or otherwise. 2. Date of Appointment/Re-appointment, With effect from 30th September, 2026. Cessation (as applicable) 3. term of appointment/ re-appointment The members at its meeting held on August 31, 2026, has approved the re-appointment of Mr. Aditya Arora (DIN: 07320410) as Whole Time Director of the Company w.e.f. 30th September, 2026 for a period of 5 years i.e. upto 29th September, 2031, and his office shall be liable to retire by rotation. 4. brief profile (in case of Mr. Aditya Arora is the Whole Time Director of the Company. He Appointment/Re-appointment) holds a Bachelor’s degree in Commerce from the Delhi University. He has been associated with the Board of the Company since October 2015. He joined the company at a young age, bringing youthful energy and new perspectives, and made significant contributions towards the vision of making the company one of the leading manufacturers of finished pharmaceutical products. He oversees the production, quality assurance and quality control functions across all manufacturing units and regulatory filings of the Company. He is actively driving operational excellence by aligning these functions with evolving industry standards and next -generation requirements. With his dynamic leadership, proactive approach and strong commitment to operational efficiency, he continues to play key role in the Company’s growth and long term success. 5. Disclosure of relationships between Mr. Ajay Kumar Arora- Father Directors Mrs. Geeta Arora- Mother Mr. Ramesh Kumar- Father’s Brother Mrs. Anju Arora- Father’s Brother’s Wife 6. Information as required pursuant to Mr. Aditya Arora is not debarred from holding the office of Director BSE Circular with ref. no. by virtue of any SEBI order or any such authority. LIST/COMP/14/2018-19